USPSTF Affirms Evidence-Based Methods for Smoking Cessation
Behavioral and pharmacotherapy interventions, alone or in combination, recommended; evidence insufficient for e-cigarettes
California First State With Over 3 Million COVID-19 Cases
Biden administration has said it will not be lifting restrictions on international travel
One-Third of U.S. Adults Likely to Refuse a COVID-19 Vaccine
Blacks, women, and conservatives more hesitant in the United States
Stopping RAS Inhibitors May Worsen Outcomes in CKD
Stopping therapy tied to lower risk for dialysis, but higher risk for cardiovascular events and death
Physician’s Briefing Weekly Coronavirus Roundup
Primary Care-Recorded Mental Illness Decreased During COVID-19
Reductions seen in incidence of primary care-recorded depression, anxiety disorders, first antidepressant prescribing in United Kingdom
Bupropion-Naltrexone Bests Placebo in Methamphetamine Use Disorder
Response was low but higher with naltrexone-bupropion than placebo during 12-week, two-stage trial
U.S. COVID-19 Vaccine Rollout Nears 1 Million Doses Per Day
News comes as Ohio State University researchers discover new variant of COVID-19 virus
Inhaled Treprostinil Beneficial in Pulmonary Hypertension
Exercise capacity improved, clinical worsening reduced for patients with pulmonary HTN due to interstitial lung disease
Ad26.COV2-S Vaccine Seems Safe, Immunogenic for SARS-CoV-2
Neutralizing antibodies detected in 90 percent or more of all participants on day 29 after the first vaccine dose